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Conclusion: Postpartum hypertension is more recognized, and
readmissions are becoming more common. We increased efforts
to optimize medical management of hypertension and reduce
preventable readmissions. Improvement in discharge instructions
for patients did not decrease overall admission for postpartum
hypertension but may have improved overall patient care. Overall
cost analysis would be beneficial to see further economic impact.
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Background: Surgical management for endometrioid endometrial
cancer (EEC) includes complete lymph node dissection for all
patients at risk of lymphatic dissemination. The standard risk
schema, defined by Mayo Clinic, identifies low-risk patients as
those with grade 1/2 EEC, myometrial invasion (MI) ≤ 50%, and
tumor diameter (TD) ≤ 2 cm. We recently proposed (and published)
a risk schema containing modified forms of grade, MI and TD that
suggests a significant decrease in false-negative rate and need for
lymphadenectomy in low-risk women.
Purpose: Evaluate robustness of our proposed schema for lymphatic
dissemination risk stratification in a subsequent EEC patient cohort.
Methods: We retrospectively applied the proposed schema to
patients diagnosed with stage I–III EEC during 2014–2015 who
underwent pelvic and/or para-aortic lymph node removal. Cancer
Registry data were confirmed via chart review. Consistent with the
cohort studied during model development, the validation cohort
included non-Hispanic white or black patients with complete data
describing TD (≤50 mm or >50 mm), MI (≤33%, >33% to ≤66%, or
>66%) and grade (1 or 2–3).
Results: In the validation cohort, 29 (11.7%) of the 247 EEC patients
were node-positive (vs 9.2% of 737 patients in the development
cohort). Risk stratification using the proposed schema produced
similar false-positive rates during model development (57.2%) and
validation (54.6%), both 20% lower than when using the standard
schema (76.2% and 74.3%, respectively). False-negative rates,
however, were noticeably different between development and
validation cohorts using both the proposed (0% and 13.8%) and
standard (1.47% and 6.90%) schemas, suggesting a shift toward lowrisk classification in node-positive patients of the validation cohort.
Conclusion: Application of the proposed risk stratification schema
to an alternative patient cohort verified the utility of modified risk
criteria, including TD with 50-mm cutoff, for identifying low-risk
EEC patients who may not require node evaluation. However, in
the validation cohort, greater prevalence of lymph node metastasis
and low-risk classification of node-positive patients was observed.
Discrepancy between cohorts is likely due to greater utilization of
sentinel lymph node mapping during the validation period, allowing
for increased detection of low-volume metastases. Continued model
development and validation is needed, especially to account for the
increased sensitivity of new technologies.
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Background: Fecal transplants are successful in the treatment of
recurrent or refractory Clostridium difficile infections (CDI), but
there is no consensus on the best method of instillation. Studies have
shown greater success with lower gastrointestinal tract placement,
but technical aspects of placement are not validated.
Purpose: This review aims to identify common traits and procedural
techniques of successful fecal microbiota transplant (FMT) therapy
via colonoscopy.
Methods: An electronic search was conducted using OVID Medline
and PubMed for articles published from January 2010 to January
2016. The primary outcome of interest was cure by FMT placed via
colonoscopy.
Results: Of the 337 articles reviewed, we included 24 studies,
from which 11 case reports were excluded from data analysis. The
resultant data included 366 patients (64% female). Point estimate
for cure of CDI after FMT for patients over 65 years of age (9%)
was 84.6% (95% confidence interval [CI]: 0.58–0.96; P<0.016),
cure over the age of 18 with no upper limit specified on age (74%)
was 85.4% (95% CI: 0.76–0.91; P<0.001) and, for those identified
strictly as 18–65 years old (17%), cure was 93% (95% CI: 0.83–
0.98; P<0.001). Patients who stopped antibiotics at least 48 hours
prior to FMT (37%) had a cure rate of 86% (95% CI: 0.78–0.91;
P<0.001) compared to 95% (95% CI: 0.90–0.98; P<0.001) in
patients who stopped antibiotics at least 24 hours prior to FMT
(43%) and 81% (95% CI: 0.53–0.94; P<0.035) in those who stopped
less than 24 hours prior to FMT (15%). In studies that specified use
of GoLYTELY® prep prior to colonoscopy (58%), cure was 91%
(95% CI: 0.85–0.95; P<0.001); whereas those using a split 2-L
polyethylene glycol prep (21%) had 79% cure (95% CI: 0.61–0.90;
P<0.004). Placement of FMT throughout the colon (6.8%) had 96%
cure (95% CI: 0.77–0.99; P<0.002) versus terminal ileum to cecum
placement (59%) at 88% cure (95% CI: 0.78–0.94; P<0.001) and
cecum to ascending colon (28%) at 86% cure (95% CI: 0.63–0.95;
P<0.006). Studies that specified the use of loperamide after FMT
(21%) had a cure of 85% (95% CI: 0.63–0.95; P<0.004).
Conclusion: FMT placed by colonoscopy has a role in the cure of
recurrent or refractory CDI. Stopping antibiotics 24 hours prior to
FMT results in higher percentage cure (95%). Distribution of FMT
throughout the colon has better outcomes than FMT instillation at
other locations. Effect of loperamide post-FMT placement is not
conclusive due to the low percentage of reported use. Prospective
studies are recommended to study these factors for confirmation of
effects.
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